knowledge -WSS

knowledge

author：knowledge 2025-09-06 03:26:37 - browse：4639

Patient treated with Impella in the heart. -- health tech coverage from STAT — Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. Business Wire

The Food and Drug Administration is following through on its promise to regulate more health software tools, starting with a public reprimand of Johnson & Johnson’s heart pump company, Abiomed.

Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. The FDA published a warning letter on Wednesday telling the company it should have submitted its software for approval before putting it on the market. The agency also took issue with Abiomed’s failure to report various problems with its heart pumps.

The letter comes a year after the Food and Drug Administration announced its intention to regulate more health software tools, sending the industry into an uproar.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Kaiser Permanente unions announce official strike date

focus

WSS

Ionis has late

FDA seeks to regulate lab

How the Dana

Covid vaccines: Private market messier than government rollout

NIH fellows want a pay raise. Will that mean less money for grants?

Beach reads and more: STAT's 2023 summer book list

Wikipedia

knowledge

knowledge

Peter Hotez and the public health issue of online harassment

After a drawn out lobbying fight, ARPA

Drug repurposing or repositioning? The language matters

New research casts further doubt on a common procedure used with IVF

Virginia high school admissions case could be legal follow

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

Hepatitis C has a cure — but many Americans still lack access to it

A new study sees potential in DNA sequencing of infants

BioMarin wins approval for gene therapy to treat hemophilia A

Researchers use wearables data and AI to predict preterm birth risk

explore

N.Y. state detects polio case, first in the U.S. since 2013

STAT Virtual Event: How to Increase Diversity in Clinical Trials

Did you have Obamacare on your GOP debate bingo card?

HCA discloses massive data breach affecting 11 million patients

Dozens of Pride flags vandalized at Stonewall monument in NYC, 3rd time this month: Police

After a drawn out lobbying fight, ARPA

explore

focus

leisure time

entertainment